Lv4
470 积分 2026-02-11 加入
Abemaciclib plus endocrine therapy for hormone receptor-positive, HER2-negative, node-positive, high-risk early breast cancer (monarchE): results from a preplanned interim analysis of a randomised, open-label, phase 3 trial
3天前
已完结
Overall Survival with Pembrolizumab in Early-Stage Triple-Negative Breast Cancer
3天前
已完结
Clinical and Biomarker Findings of Neoadjuvant Pembrolizumab and Carboplatin Plus Docetaxel in Triple-Negative Breast Cancer
3天前
已完结
Trastuzumab Deruxtecan in Residual HER2-Positive Early Breast Cancer
3天前
已完结
De-escalated neoadjuvant weekly nab-paclitaxel with trastuzumab and pertuzumab versus docetaxel, carboplatin, trastuzumab, and pertuzumab in patients with HER2-positive early breast cancer (HELEN-006): a multicentre, randomised, phase 3 trial
3天前
已完结
Using Vision Transformer for high robustness and generalization in predicting EGFR mutation status in lung adenocarcinoma
2个月前
已完结
Current status and prospects of artificial intelligence in breast cancer pathology: convolutional neural networks to prospective Vision Transformers
2个月前
已完结
Hierarchical image pyramid transformer framework for automated breast cancer molecular subtyping using tissue microarrays
2个月前
已完结
Double Transformer Super-Resolution for Breast Cancer ADC Images
2个月前
已完结
Toward Accurate Deep Learning-Based Prediction of Ki67, ER, PR, and HER2 Status From H&E-Stained Breast Cancer Images
2个月前
已完结
皖公网安备34019202002308
